Alpha Omega Wealth Management’s Globus Medical GMED Stock Holding History

Alpha Omega Wealth Management’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-45	Closed	-$2K	–	355
2019 Q2	$2K	Hold	45	–	–	﹤0.01%	560
2019 Q1	$2K	Buy	+45	New	+$2.04K	﹤0.01%	529

Other funds holding GMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Alpha Omega Wealth Management's GMED Position: Q3 2019 in Review

Alpha Omega Wealth Management sold out of Globus Medical (GMED) in Q3 2019, closing a stake of 45 shares — an estimated $2K sold.

Alpha Omega Wealth Management first reported a position in GMED in Q1 2019 and held it in 2 quarters. The position peaked at $2K in Q2 2019. 268 funds tracked by Wall St. Rank hold GMED as of Q3 2019.

Alpha Omega Wealth Management reported no remaining Globus Medical position as of Q3 2019 after selling out during the quarter.
Alpha Omega Wealth Management sold 45 Globus Medical shares in Q3 2019, an estimated $2K.
Alpha Omega Wealth Management first reported a position in Globus Medical in Q1 2019 and held it in 2 quarters.
Alpha Omega Wealth Management's Globus Medical position peaked at $2K in Q2 2019.
268 funds tracked by Wall St. Rank held Globus Medical as of Q3 2019.

Based on Alpha Omega Wealth Management's 13F filing for Q3 2019, filed 12 Nov 2019.